Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "Waligórska, Agnieszka" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Human SUV3 helicase regulates growth rate of the HeLa cells and can localize in the nucleoli
Autorzy:
Szewczyk, Maciej
Fedoryszak-Kuśka, Natalia
Tkaczuk, Katarzyna
Dobrucki, Jurek
Waligórska, Agnieszka
Stępień, Piotr
Powiązania:
https://bibliotekanauki.pl/articles/1038704.pdf
Data publikacji:
2017
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
SUV3 helicase
SUPV3L1
dual targeting
nucleolus
mitochondria
cell cycle
Opis:
The human SUV3 helicase (SUV3, hSUV3, SUPV3L1) is a DNA/RNA unwinding enzyme belonging to the class of DexH-box helicases. It localizes predominantly in the mitochondria, where it forms an RNA-degrading complex called mitochondrial degradosome with exonuclease PNP (polynucleotide phosphorylase). Association of this complex with the polyA polymerase can modulate mitochondrial polyA tails. Silencing of the SUV3 gene was shown to inhibit the cell cycle and to induce apoptosis in human cell lines. However, since small amounts of the SUV3 helicase were found in the cell nuclei, it was not clear whether the observed phenotypes of SUV3 depletion were of mitochondrial or nuclear origin. In order to answer this question we have designed gene constructs able to inhibit the SUV3 activity exclusively in the cell nuclei. The results indicate that the observed growth rate impairment upon SUV3 depletion is due to its nuclear function(s). Unexpectedly, overexpression of the nuclear-targeted wild-type copies of the SUV3 gene resulted in a higher growth rate. In addition, we demonstrate that the SUV3 helicase can be found in the HeLa cell nucleoli, but it is not detectable in the DNA-repair foci. Our results indicate that the nucleolar-associated human SUV3 protein is an important factor in regulation of the cell cycle.
Źródło:
Acta Biochimica Polonica; 2017, 64, 1; 177-181
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Feeling of loneliness in adolescents with autism spectrum disorders
Autorzy:
Siedler, Agnieszka
Waligórska, Anna
Woś, Jarosław
Kałowski, Piotr
Powiązania:
https://bibliotekanauki.pl/articles/27320906.pdf
Data publikacji:
2020
Wydawca:
Akademia Pedagogiki Specjalnej im. Marii Grzegorzewskiej. Wydawnictwo APS
Tematy:
loneliness
cognitive functions
autism spectrum disorders
Asperger Syndrome
Opis:
A key characteristic of autism spectrum disorder (ASD) are the difficulties in social interaction, comprising deficits in communication, reflecting of emotional states, and social competences. Difficulties in establishing and maintaining social relationships and functioning in peer groups are also frequent, which can lead to intense feelings of loneliness. The aim of the current study was to examine the relationships between the sense of loneliness, the intensity of autism spectrum traits, and cognitive functioning – especially verbal fluency. Fifty adolescents with ASD, aged between 13 and 19 years, together with 50 typically developing adolescents took part in the study. The study had a questionnaire character and used the Polish versions of the De Jong Gierveld Sense of Loneliness Scale and the adolescent version of Simon Baron-Cohen’s Autism Quotient Questionnaire. The participants’ cognitive functioning was tested during individual in-person meetings. The results showed that the sense of loneliness is related both to the presence of ASD as well as the intensity of its expression. Some relationships between the sense of loneliness and cognitive functioning test results were also revealed in the group of adolescents with ASD. Based on the obtained results, it can be concluded that the perception of loneliness by ASD adolescents might be moderated by their level of cognitive functioning. However, these conclusions require further studies, which should include additional measures of cognitive functioning.
Źródło:
Psychologia Wychowawcza; 2020, Special issue; 46-54
0033-2860
Pojawia się w:
Psychologia Wychowawcza
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Factors affecting the course of Graves orbitopathy and poor response to glucocorticoid treatment followed by orbital radiotherapy
Autorzy:
Jagiełło-Korzeniowska, Agnieszka
Sokołowski, Andrzej
Hubalewska-Dydejczyk, Alicja
Romanowska-Dixon, Bożena
Bałdys-Waligórska, Agata
Powiązania:
https://bibliotekanauki.pl/articles/2159024.pdf
Data publikacji:
2022-05-19
Wydawca:
Medical Education
Tematy:
Graves' orbitopathy
Graves' disease
TRAb
NOSPECS
glucocorticoid treatment
orbital radiotherapy
Opis:
Graves’ orbitopathy is a rare autoimmune disorder characterized by the inflammation of orbital tissues. The course of disease can be described in terms of its activity and severity. Aim: The aim of our study was to determine the factors affecting the activity and severity of Graves’ orbitopathy, as well as to identify the predictive factors of poor response to glucocorticoid treatment followed by orbital irradiation. Methods: We performed a prospective observational study of 214 patients with Graves’ orbitopathy who were divided into two groups depending on the treatment they had previously obtained for their Graves’ disease. They received i.v. methylprednisolone pulses followed by orbital radiotherapy. They were examined and had their TSH, TRAb and FT4 levels evaluated prior to treatment and after 1, 6 and 12 months. Results: A pre-treatment TRAb concentration higher by one unit (U/L) implied a mean increase in the relative risk of active orbitopathy by 4.7% (p = 0.0362). A TRAb concentration higher by one U/L 1 month after treatment implied a mean increase in the relative risk of moderate-to-severe and severe GO by 8.7% (p = 0.0167) 6 months after treatment. As regards poor response to treatment, patients with moderate-to-severe and severe Graves’ orbitopathy on admission carried a higher risk of being non-responders. Each point scored on the NOSPECS scale prior to treatment increased the relative risk of the patient being a non-responder by 30%. Conclusions: Patients with higher TRAb levels have a higher risk of active Graves’ orbitopathy and moderate-to-severe and severe Graves’ orbitopathy. Monitoring TRAb serum concentration in those patients is of great importance. Patients with more severe Graves’ orbitopathy carry a higher risk of being poor responders to immunosuppressive treatment. Therefore, careful monitoring of patients with Graves’ orbitopathy and their early referral to specialized centers is essential.
Źródło:
OphthaTherapy; 2022, 9, 2; 98-105
2353-7175
2543-9987
Pojawia się w:
OphthaTherapy
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies